Allostere - Crunchbase Company Profile & Funding

Overview

Allostere

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Allostere

CB Rank

357889

Allostere is a biotech company that provides novel allosteric drug research.

Private

San Diego, California, United States

11-50

www.allostere.com

Biopharma

Biotechnology

Product Research

Key People

Robert Mathvink: Director of Chemistry and Co-Founder
Anton Cheltsov: Chief Technology Officer and Co-Founder

Details

Legal Name

Allostere, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Anton Cheltsov, Ekaterina Bobkova, Robert Mathvink

About the Company

Allostere develops oncogenes, neddylation genes, ubiquitination enzymes, PI3 kinase cancer pathways, and metastatic mechanisms. Currently, there are serious issues with drugs developing resistance.

Contact Email

info@allostere.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Q-MOL™ Technology

A computational technology for discovering and designing ligands for allosteric sites and protein-protein interactions, using a proprietary algorithm for virtual ligand screening and protein-ligand docking.

Allosteric Drug Discovery

Focuses on developing ligands for allosteric and protein-protein interactions to create novel therapies with fewer side effects and lower toxicity.